World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on August 25, 2026

Aug. 25, 2026

SERB Applauds Publication of Consensus Statements and Recommendations for Neuroblastoma Care in Pediatric Blood & Cancer

Indeterminate GlobeNewswire

Aug. 25, 2026

Immatics Announces $150 Million Underwritten Offering

Indeterminate GlobeNewswire

Aug. 25, 2026

Aveanna to Participate in the 2026 Jefferies Healthcare Services and Technology Conference

Indeterminate GlobeNewswire

Aug. 25, 2026

Apollo Therapeutics Announces Positive Immunogenicity Data and Cross-Species Activity from Phase 1 Trial of APL-10456, a Pan-Rhinovirus Vaccine for the Prevention of COPD Exacerbations

Indeterminate GlobeNewswire

Aug. 25, 2026

BrewDog Wins Big at the 2026 World Beer Awards with a Sweeping Show of Brewing Excellence

Indeterminate GlobeNewswire

Aug. 25, 2026

Gain Therapeutics to Participate at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Aug. 25, 2026

Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors

Indeterminate GlobeNewswire

Aug. 25, 2026

Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments

Indeterminate GlobeNewswire

Aug. 25, 2026

Sagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026

Indeterminate GlobeNewswire

Aug. 25, 2026

Astrocyte Pharmaceuticals Receives NIH Award to Evaluate AST-004 in Substance Use Disorders

Indeterminate GlobeNewswire

Aug. 25, 2026

Revier Therapeutics startet mit 6 Mio. € Seed-Finanzierung zur Entwicklung von Klasse-IIa-HDAC-Inhibitoren für kardiometabolische Erkrankungen

Indeterminate GlobeNewswire

Aug. 25, 2026

Revier Therapeutics Launches with €6 Million Seed Financing to Pioneer Class IIa HDAC Inhibitors for Cardiometabolic Disease

Indeterminate GlobeNewswire

Aug. 25, 2026

Les Canadiens champions de la longévité... en mauvaise santé

Indeterminate GlobeNewswire

Aug. 25, 2026

CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market

Indeterminate GlobeNewswire

Aug. 25, 2026

Vocalbeats.AI Applications Gain Strong Momentum in 2026, Reaching Top-Grossing Charts Worldwide

Indeterminate GlobeNewswire

Aug. 25, 2026

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage

Indeterminate GlobeNewswire

Aug. 25, 2026

Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules

Indeterminate GlobeNewswire